ENTA - Enanta Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ENTA is currently covered by 4 analysts with an average price target of $27.81. This is a potential upside of $14.91 (115.58%) from yesterday's end of day stock price of $12.9.

Enanta Pharmaceuticals's activity chart (see below) currently has 175 price targets and 112 ratings on display. The stock rating distribution of ENTA is 90% BUY and 10% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.78% with an average time for these price targets to be met of 101 days.

Highest price target for ENTA is $28, Lowest price target is $12, average price target is $21.67.

Most recent stock forecast was given by ERIC JOSEPH from JPMORGAN on 14-Nov-2025. First documented stock forecast 24-Jun-2014.

Currently out of the existing stock ratings of ENTA, 9 are a BUY (90%), 1 are a SELL (10%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Nov-2025

$5

2 months 16 days ago
(14-Nov-2025)

8/9 (88.89%)

$-0.59 (-10.55%)

98

Buy Since 09-Dec-2022

$28

$14.98 (115.05%)

$24

4 months ago
(30-Sep-2025)

0/14 (0%)

$16.03 (133.92%)

Buy Since 06-Jul-2022

$12

$-1.02 (-7.83%)

$62

4 months 15 days ago
(15-Sep-2025)

6/6 (100%)

$4.54 (60.86%)

150

Buy Since 27-Jul-2020

$25

$11.98 (92.01%)

$24

5 months 18 days ago
(12-Aug-2025)

6/21 (28.57%)

$18.14 (264.43%)

144

$14

$0.98 (7.53%)

$21

1 years 2 months 3 days ago
(27-Nov-2024)

8/13 (61.54%)

$5.17 (58.55%)

91

Show more analysts

Please expand the browser size to see the chart

What is ENTA (Enanta Pharmaceuticals) average time for price targets to be met?

On average it took 101 days on average for the stock forecasts to be realized with a an average price target met ratio 51.78

Which analyst has the current highest performing score on ENTA (Enanta Pharmaceuticals) with a proven track record?

YASMEEN RAHIMI

Which analyst has the most public recommendations on ENTA (Enanta Pharmaceuticals)?

Yasmeen Rahimi works at PIPER SANDLER and has 1 price targets and 5 ratings on ENTA

Which analyst is the currently most bullish on ENTA (Enanta Pharmaceuticals)?

Patrick Trucchio with highest potential upside - $106.98

Which analyst is the currently most reserved on ENTA (Enanta Pharmaceuticals)?

Liisa Bayko with lowest potential downside - -$1.02

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?